SCHEMBL30784386

SCHEMBL30784386

CCn1c(N2CCOCC2)nc2c(C(C)N)cc(Cl)cc2c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 4/20 0.37
▸ S1PR1 P21453 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ STAT6 P42226 1/20 0.37
▸ SOS1 Q07889 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ ESR2 Q92731 1/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30783932 0.88 PIK3CB (0.38) DPP4POLBMAPK1GAAPIK3CB
SCHEMBL30784248 0.88 METAP2 (0.37) DPP4SMN1; SMN2LMNASTAT6SOS1
SCHEMBL30784178 0.86 PDE1A (0.39) DPP4SMN1; SMN2LMNASTAT6SOS1
SCHEMBL30784172 0.86 HTT (0.39) DPP4SMN1; SMN2LMNASTAT6POLB
SCHEMBL30783939 0.85 PIK3CB (0.40) DPP4POLBMAPK1PIK3CB
SCHEMBL30783979 0.79 PIK3CB (0.45) S1PR1SOS1PIK3CB
SCHEMBL30783599 0.78 PIK3CB (0.37) DPP4POLBALDH1A1MEN1KMT2A
SCHEMBL30784369 0.77 PIK3CB (0.38) METAP2PIK3CB
SCHEMBL30783773 0.76 CYP1A2 (0.44) DPP4POLBALDH1A1CYP3A4MEN1
SCHEMBL30783794 0.74 HTT (0.40) DPP4SMN1; SMN2LMNASTAT6SOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback